TrademarkDir
XILIO
LIVE

Serial Number

88981673

Owner

Akrevia Therapeutics, Inc.

Attorney

Valerie Brennan

First Use Date

Mar 2, 2021

Filing Date

Feb 3, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

XILIO Trademark

Serial Number: 88981673 • Registration: 6435654

XILIO is a trademark filed by Akrevia Therapeutics, Inc. on February 3, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Akrevia Therapeutics, Inc.

610 Main Street
Cambridge, MA 02139

Entity Type: 03

XILIO DEVELOPMENT, INC. (7 trademarks)

Waltham, MA 02139

Entity Type: 03

Trademark Details

Filing Date

February 3, 2020

Registration Date

July 27, 2021

First Use Anywhere

March 2, 2021

First Use in Commerce

March 2, 2021

Published for Opposition

June 2, 2020

Goods & Services

Pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer, all of the foregoing excluding research and development services for pharmaceutical products for sleep disorders, central nervous disorders (other than cancers of the central nervous system), and neurological disorders (other than cancers of the neurological system)

Filing History

TEAS SECTION 8 & 15 RECEIVED
Jul 28, 2026 E815
TEAS SECTION 8 & 15 RECEIVED
Jul 28, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 27, 2026 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 27, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 27, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
Jul 27, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 23, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 22, 2021 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 19, 2021 EXRA
STATEMENT OF USE PROCESSING COMPLETE
May 18, 2021 SUPC
SOU EXTENSION 1 GRANTED
May 18, 2021 EX1G
DIVISIONAL PROCESSING COMPLETE
May 18, 2021 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 26, 2021 AITU
SOU EXTENSION 1 FILED
Apr 6, 2021 EXT1
USE AMENDMENT FILED
Apr 6, 2021 IUAF
DIVISIONAL REQUEST RECEIVED
Apr 6, 2021 DRRR
SOU TEAS EXTENSION RECEIVED
Apr 6, 2021 EEXT
TEAS STATEMENT OF USE RECEIVED
Apr 6, 2021 EISU
TEAS REQUEST TO DIVIDE RECEIVED
Apr 6, 2021 ERTD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 8, 2020 NOAM
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Nov 25, 2020 ASCK
POST PUBLICATION AMENDMENT - ENTERED
Oct 28, 2020 CHPB
ASSIGNED TO PETITION STAFF
Oct 27, 2020 APET
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 14, 2020 ASGN
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Oct 11, 2020 ETOP
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 16, 2020 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 29, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 2, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 2, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2020 CNSA
ASSIGNED TO EXAMINER
Apr 22, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2020 NWOS
NEW APPLICATION ENTERED
Feb 6, 2020 NWAP

Related Trademarks

More from this Owner

XILIO

XILIO

XILIO

XILIO

XILIO THERAPEUTICS

XILIO THERAPEUTICS

XILIO THERAPEUTICS

XILIO THERAPEUTICS

XILIO THERAPEUTICS

XILIO THERAPEUTICS

XILIO

XILIO